Experimental infection and protection against ... - TI Pharma
Experimental infection and protection against ... - TI Pharma
Experimental infection and protection against ... - TI Pharma
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Introduction 25<br />
50. Ouedraogo AL, Roeffen W, Luty AJ et al. Naturally acquired immune responses<br />
to Plasmodium falciparum sexual stage antigens Pfs48/45 <strong>and</strong> Pfs230 in an area<br />
of seasonal transmission. Infect Immun 2011; 79:4957-4964.<br />
51. Saul A. Mosquito stage, transmission blocking vaccines for malaria. Curr Opin<br />
Infect Dis 2007; 20:476-481.<br />
52. Wu Y, Ellis RD, Shaffer D et al. Phase 1 trial of malaria transmission blocking<br />
vaccine c<strong>and</strong>idates Pfs25 <strong>and</strong> Pvs25 formulated with montanide ISA 51. PLoS<br />
One 2008; 3:e2636.<br />
53. Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite<br />
Immunol 2006; 28:51-60.<br />
54. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. Immunity to noncerebral<br />
severe malaria is acquired after one or two <strong>infection</strong>s. Nat Med 1999;<br />
5:340-343.<br />
55. Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol<br />
Rev 2009; 22:13-36, Table.<br />
56. Nussenzweig RS, Nussenzweig V. Antisporozoite vaccine for malaria:<br />
experimental basis <strong>and</strong> current status. Rev Infect Dis 1989; 11 Suppl 3:S579-<br />
S585.<br />
57. Tsuji M, Zavala F. T cells as mediators of protective immunity <strong>against</strong> liver<br />
stages of Plasmodium. Trends Parasitol 2003; 19:88-93.<br />
58. Doolan DL, Hoffman SL. The complexity of protective immunity <strong>against</strong> liverstage<br />
malaria. J Immunol 2000; 165:1453-1462.<br />
59. McCall MB, Sauerwein RW. Interferon-gamma--central mediator of protective<br />
immune responses <strong>against</strong> the pre-erythrocytic <strong>and</strong> blood stage of malaria. J<br />
Leukoc Biol 2010; 88:1131-1143.<br />
60. Doolan DL, Martinez-Alier N. Immune response to pre-erythrocytic stages of<br />
malaria parasites. Curr Mol Med 2006; 6:169-185.<br />
61. Yazdani SS, Mukherjee P, Chauhan VS, Chitnis CE. Immune responses to asexual<br />
blood-stages of malaria parasites. Curr Mol Med 2006; 6:187-203.<br />
62. Good MF, Xu H, Wykes M, Engwerda CR. Development <strong>and</strong> regulation of cellmediated<br />
immune responses to the blood stages of malaria: implications for<br />
vaccine research. Annu Rev Immunol 2005; 23:69-99.<br />
63. Cohen S, McGregor IA, Carrington S. Gamma-globulin <strong>and</strong> acquired immunity to<br />
human malaria. Nature 1961; 192:733-737.<br />
64. Sabchareon A, Burnouf T, Ouattara D et al. Parasitologic <strong>and</strong> clinical human<br />
response to immunoglobulin administration in falciparum malaria. Am J Trop<br />
Med Hyg 1991; 45:297-308.<br />
65. Kennedy MC, Wang J, Zhang Y et al. In vitro studies with recombinant<br />
Plasmodium falciparum apical membrane antigen 1 (AMA1): production <strong>and</strong><br />
activity of an AMA1 vaccine <strong>and</strong> generation of a multiallelic response. Infect<br />
Immun 2002; 70:6948-6960.<br />
66. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T,<br />
Druilhe P. Antibodies that protect humans <strong>against</strong> Plasmodium falciparum<br />
blood stages do not on their own inhibit parasite growth <strong>and</strong> invasion in vitro,<br />
but act in cooperation with monocytes. J Exp Med 1990; 172:1633-1641.